PlainRecalls
FDA Drug Low Class III Terminated

TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01

Reported: April 3, 2013 Initiated: November 26, 2012 #D-219-2013

Product Description

TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01

Reason for Recall

Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.

Details

Recalling Firm
Pfizer Inc.
Units Affected
10920 kits
Distribution
Nationwide
Location
New York, NY

Frequently Asked Questions

What product was recalled?
TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01. Recalled by Pfizer Inc.. Units affected: 10920 kits.
Why was this product recalled?
Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 3, 2013. Severity: Low. Recall number: D-219-2013.